SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Cell Origin Biotech (Hangzhou) Co., Ltd.
Cell Origin Biotech (Hangzhou) Co., Ltd.
University of Florida
Hospital del Mar
Chang Gung Memorial Hospital
Silesian Centre for Heart Diseases
Rigshospitalet, Denmark
Soonchunhyang University Hospital
Centre Leon Berard
Canada Royal Enoch Phytomedicine Co., Ltd.
Gynaecologisch Oncologisch Centrum Zuid
Sixth Affiliated Hospital, Sun Yat-sen University